Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus and Trastuzumab in HER2-positive breast cancer
NCT00674414Phase 2Terminated
- Sponsor
- Unicancer
- Start
- Apr 2008
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in breast cancer, sponsored by Unicancer. Started Apr 2008; status: terminated.
02
Drugs
everolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00674414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00674414.